ArticleMolecular biology reports2025
T16 modulated extracellular matrix remodeling in fibroblasts via paracrine activation of TGF-β1 through M2 macrophage polarization.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Probing uric acid-related prognostic genes and their molecular mechanisms in prostate cancer based on transcriptomic data.Discover oncology · 2026Article
- From uric acid to tophi: multistage molecular and cellular mechanisms of tophi formation.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundT16 has demonstrated significant potential for regulating extracellular matrix (ECM) remodeling by modulating immune and fibroblast functions. This study investigated how T16 influences fibroblast-mediated extracellular matrix (ECM) remodeling through macrophage polarization.
methodsUterosacral ligaments were collected from 15 patients with pelvic organ prolapse (POP) and 6 patients without pelvic organ prolapse (POP). Fibroblasts isolated from these tissues were cultured and co-cultured with THP-1-derived macrophages in the following experimental groups: control, T16 + fibroblasts, M1 macrophages + fibroblasts, and T16 + M1 macrophages + fibroblasts. Cell proliferation was assessed using the CCK-8 assay, while protein and mRNA expression levels were analyzed by western blotting and qRT-PCR, respectively.
resultsOur findings revealed that T16 promoted macrophage polarization toward the anti-inflammatory M2 phenotype, which, in turn, exerted paracrine effects on fibroblasts. Specifically, M2 macrophages induced by T16 significantly enhance the activation of transforming growth factor beta-1 (TGF-β1), a key regulator of extracellular matrix (ECM) synthesis and remodeling. This paracrine signaling pathway facilitates fibroblast-mediated ECM stabilization, characterized by increased collagen synthesis and extracellular matrix turnover.
conclusionThese results highlight the therapeutic potential of T16 in conditions involving extracellular matrix (ECM) dysfunction, such as pelvic organ prolapse (POP), by targeting the crosstalk between immune cells and fibroblasts. Further research is required to explore its applications in regenerative medicine and tissue engineering.
Indexed as
Identifiers
40569521What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.